Literature DB >> 12810059

Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption process.

R Mentaverri1, S Kamel, M Brazier.   

Abstract

Bone resorption is closely dependent on osteoclastic survival and osteoclast apoptotic cell death could represent a key step at the end of this process. In order to precise the possible role of calcium movement in osteoclastic cell death, we investigated whether intracellular calcium store replenishment and capacitive calcium entry (CCE) are involved in osteoclastic survival and bone resorption. We demonstrate that (i). thapsigargin, a sarco-endoplasmic reticulum calcium ATPase pump (SERCA) blocker, decreases both osteoclastic survival and bone resorption process, (ii). 2-aminoethoxydiphenyl borate (2-APB) and SKF-96365, two store-operated channel (SOC) blockers, dramatically decrease osteoclastic survival and bone resorption and (iii). culture in calcium-free medium and thapsigargin exposure synergically inhibit osteoclastic survival which falls dramatically to a value close to 0% (P<0.001). Inversely, osteoclastic survival increases significantly when thapsigargin-treated cells are cultured in the presence of 20mM calcium, suggesting that increasing extracellular calcium concentration stimulates osteoclasts survival when the filling of intracellular stores is prevented. Taken together, our data strongly suggest that in osteoclasts, calcium movements between cellular compartments involved in the regulation of calcium signalling, such as calcium stores refilling and CCE, are closely associated to the regulation of osteoclast survival and bone resorption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810059     DOI: 10.1016/s0143-4160(03)00080-0

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

Review 1.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

2.  Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

3.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

4.  TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).

Authors:  Senthil Selvaraj; John A Watt; Brij B Singh
Journal:  Cell Calcium       Date:  2009-08-19       Impact factor: 6.817

5.  In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.

Authors:  M E Downey; L S Holliday; J I Aguirre; T J Wronski
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

6.  Hormone-stimulated modulation of endocytic trafficking in osteoclasts.

Authors:  Gudrun Stenbeck; Kevin M Lawrence; Anthony P Albert
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-22       Impact factor: 5.555

7.  Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation.

Authors:  Yingxiao Fu; Jianhong Gu; Yi Wang; Yan Yuan; Xuezhong Liu; Jianchun Bian; Zong-Ping Liu
Journal:  J Vet Sci       Date:  2014-12-24       Impact factor: 1.672

8.  Leukotriene B4 activates intracellular calcium and augments human osteoclastogenesis.

Authors:  Neha Dixit; Dennis J Wu; Yesser H Belgacem; Laura N Borodinsky; M Eric Gershwin; Iannis E Adamopoulos
Journal:  Arthritis Res Ther       Date:  2014-12-02       Impact factor: 5.156

9.  Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway.

Authors:  Kwang Hwan Park; Boryung Park; Dong Suk Yoon; Seung-Hyun Kwon; Dong Min Shin; Jin Woo Lee; Hyun Gyu Lee; Jae-Hyuck Shim; Jeon Han Park; Jae Myun Lee
Journal:  Cell Commun Signal       Date:  2013-10-02       Impact factor: 5.712

10.  Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.

Authors:  Sébastien S Dufresne; Antoine Boulanger-Piette; Sabrina Bossé; Jérôme Frenette
Journal:  Receptors Clin Investig       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.